Numerous groups have demonstrated a reduction in GLT-1 mRNA and/or protein expression that associates with a significant reduction in glutamate uptake capacity in striatal tissue from HD mouse models (Table 1). The gene discussed is SLC1A2; the disease is Huntington disease.